IDEXX Highlights Innovation, Workforce Investment and Sustainability Progress in 2025 Corporate Responsibility Report

IDEXX's 2025 Corporate Responsibility Report highlights new advances in veterinary diagnostics, workforce development and sustainability initiatives. The report details progress toward the company's long-term goals while showcasing investments designed to expand access to care, strengthen veterinary practices and support future innovation.

IDEXX Laboratories has released its 2025 Corporate Responsibility Report, detailing progress across innovation, workforce development, community impact and environmental sustainability. The report underscores how the company’s corporate responsibility initiatives are aligned with its long-term strategy to advance veterinary medicine and support future growth.

  • IDEXX published its 2025 Corporate Responsibility Report outlining progress toward key corporate responsibility goals.
  • The company highlighted advances in veterinary diagnostics, including the IDEXX Cancer Dx™ Panel and new cytology capabilities on the IDEXX inVue Dx™ Cellular Analyzer.
  • More than 45,000 animals in underserved communities received access to veterinary care in 2025 through IDEXX-supported initiatives.
  • IDEXX logged more than 121,000 employee learning hours and exceeded its annual volunteer goal with more than 24,000 volunteer hours.
  • The company reported continued progress toward its 2030 greenhouse gas emissions reduction target through renewable energy investments and fleet electrification.

IDEXX Laboratories has released its 2025 Corporate Responsibility Report, highlighting progress across its innovation, workforce and environmental initiatives while reinforcing the role those investments play in supporting veterinary professionals and advancing animal health.

According to the company, its corporate responsibility strategy is integrated with its long-term business objectives, focusing on innovation, employee development and sustainable operations.

Expanding Veterinary Innovation

The report outlines several diagnostic advancements introduced or advanced during 2025, including launch readiness for the IDEXX Cancer Dx™ Panel for canine lymphoma detection and expanded fine needle aspirate (FNA) cytology capabilities on the IDEXX inVue Dx™ Cellular Analyzer. IDEXX also introduced the ImageVue™ DR50 Plus Digital Imaging System, which combines artificial intelligence with reduced radiation exposure to support diagnostic imaging in veterinary practices.

Beyond product innovation, the company reported helping provide access to veterinary care for more than 45,000 animals in underserved communities during 2025, bringing the total number of animals supported through its global social initiatives since 2022 to more than 749,000.

Investing in People

IDEXX reported 121,400 employee learning hours, including 46,700 hours focused on STEM and AI training, and exceeded its annual volunteer goal with more than 24,000 volunteer hours.

Advancing Environmental Goals

The company remains on track toward its 2030 greenhouse gas emissions reduction target through renewable energy investments, fleet electrification and operational efficiency initiatives. It also signed its first European virtual power purchase agreement and reported that approximately 42% of its commercial fleet now consists of hybrid or electric vehicles.

Information sourced from the company’s press release.

Forward-looking statements: This article contains forward-looking statements based on information provided by the company, including expectations regarding future products, initiatives, operational performance and sustainability goals. Actual results may differ materially due to various risks and uncertainties. Readers should refer to the company’s SEC filings and official disclosures for additional information regarding these forward-looking statements.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.